News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Arizona
Startups
10 life sciences startups selected for accelerator program
Seven of the 10 companies participating in the fall cohorts of MassBio and SCbio’s Drive program are based in the United States, including four in Massachusetts.
September 4, 2026
·
2 min read
·
Angela Gabriel
PRESS RELEASES
Press Releases
BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa
September 24, 2026
·
4 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Begins Internal Review of First Volunteer Image Datasets for Melanoma Scan Beta
September 23, 2026
·
3 min read
Press Releases
Applied Biologics Announces Last Patient, Last Visit in CAMPX Randomized Controlled Trial of XWRAP®
September 23, 2026
·
5 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Prepares First StrainScan Pro Demonstration for Restaurant Service
September 20, 2026
·
4 min read
Press Releases
Fusion Orthopedics Announces Launch of the NEW FibFix™ Fibula Nail System at AOFAS and OTA 2026
September 17, 2026
·
4 min read
Press Releases
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
September 17, 2026
·
7 min read
Press Releases
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
September 15, 2026
·
3 min read
Press Releases
Senphonix Receives National Science Foundation Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform
September 10, 2026
·
5 min read
Press Releases
Journey Medical Corporation to Participate in September 2026 Investor Conferences
September 8, 2026
·
1 min read
Press Releases
Applied Biologics Welcomes New CMS RAPID Pathway and Expanded CMS-FDA Coordination for Innovative Medical Technologies
September 8, 2026
·
5 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Activates Volunteer Intake for Melanoma Scan Beta After Launching First Human-Submitted Dataset Initiative
September 4, 2026
·
3 min read
Press Releases
Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program
September 3, 2026
·
4 min read
Press Releases
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial
September 1, 2026
·
4 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing
August 31, 2026
·
3 min read
Press Releases
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
August 26, 2026
·
6 min read
Press Releases
Phoenix Children’s Names Perry Ann Reed Interim Senior Vice President and Chief Development Officer
August 26, 2026
·
3 min read
Press Releases
Applied Biologics Announces Acceptance of Updated CAMPX XWRAP® Clinical Trial Results for Presentation at SAWC Fall 2026
August 25, 2026
·
4 min read
Press Releases
Phoenix Children’s Names Jamie Wiggins Executive Vice President, Chief Operating Officer and Chief Nursing Executive
August 24, 2026
·
3 min read
Press Releases
Members and Leaders of HFSA to be Recognized at the 2026 Annual Scientific Meeting in Phoenix, Arizona
August 20, 2026
·
3 min read
Press Releases
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
August 20, 2026
·
12 min read